Four pairs of neolignan enantiomers with distinctive isochroman moiety from the fruits of Crataegus pinnatifida and their protective activities against H

Crataegus pinnatifida H(2)O(2)-Induced SH-SY5Y cells Rosaceae chiral resolution neolignans

Journal

Phytochemistry
ISSN: 1873-3700
Titre abrégé: Phytochemistry
Pays: England
ID NLM: 0151434

Informations de publication

Date de publication:
27 Nov 2023
Historique:
received: 11 08 2023
revised: 17 11 2023
accepted: 20 11 2023
pubmed: 30 11 2023
medline: 30 11 2023
entrez: 29 11 2023
Statut: aheadofprint

Résumé

Four pairs of neolignan enantiomers (±)-1- (±)-4 with a distinctive isochroman moiety, including seven undescribed compounds, were isolated and identified from the fruits of Crataegus pinnatifida. Structural characterization of these compounds was established through comprehensive spectroscopic analyses, as well as quantum chemical calculations of ECD and NMR data. The preliminary bioassay displayed that compounds (+)-2 and (±)-3 exerted protective activities against H

Identifiants

pubmed: 38029952
pii: S0031-9422(23)00349-7
doi: 10.1016/j.phytochem.2023.113933
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113933

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. No potential conflict of interest was reported by the authors.

Auteurs

Peng Zhao (P)

Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, China; Engineering Research Center of Natural Medicine Active Molecule Research &Development, Liaoning Province, China; Key Laboratory of Natural Bioactive Compounds Discovery &Modification, Shenyang, China; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.

Shi-Fang Li (SF)

Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, China; Engineering Research Center of Natural Medicine Active Molecule Research &Development, Liaoning Province, China; Key Laboratory of Natural Bioactive Compounds Discovery &Modification, Shenyang, China; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.

Jiao-Yang Hou (JY)

Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, China; Engineering Research Center of Natural Medicine Active Molecule Research &Development, Liaoning Province, China; Key Laboratory of Natural Bioactive Compounds Discovery &Modification, Shenyang, China; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.

Shu-Yan Qin (SY)

Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, China; Engineering Research Center of Natural Medicine Active Molecule Research &Development, Liaoning Province, China; Key Laboratory of Natural Bioactive Compounds Discovery &Modification, Shenyang, China; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.

Jia-Yi Li (JY)

Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, China; Engineering Research Center of Natural Medicine Active Molecule Research &Development, Liaoning Province, China; Key Laboratory of Natural Bioactive Compounds Discovery &Modification, Shenyang, China; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.

Xiao-Fang Zhou (XF)

Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, China; Engineering Research Center of Natural Medicine Active Molecule Research &Development, Liaoning Province, China; Key Laboratory of Natural Bioactive Compounds Discovery &Modification, Shenyang, China; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.

Xuan Liu (X)

Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, China; Engineering Research Center of Natural Medicine Active Molecule Research &Development, Liaoning Province, China; Key Laboratory of Natural Bioactive Compounds Discovery &Modification, Shenyang, China; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.

Jin-Le Hao (JL)

School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, 110016, China.

Bin Lin (B)

Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address: randybinlin@gmail.com.

Xiao-Xiao Huang (XX)

Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, China; Engineering Research Center of Natural Medicine Active Molecule Research &Development, Liaoning Province, China; Key Laboratory of Natural Bioactive Compounds Discovery &Modification, Shenyang, China; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address: xiaoxiao270@163.com.

Shao-Jiang Song (SJ)

Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, China; Engineering Research Center of Natural Medicine Active Molecule Research &Development, Liaoning Province, China; Key Laboratory of Natural Bioactive Compounds Discovery &Modification, Shenyang, China; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address: songsj99@163.com.

Classifications MeSH